< Back to Press Releases

Monthly Archives: November 2016

Anti-cancer drug, CB-839, in combination with everolimus, stops tumours growing in patients with advanced kidney cancer

Munich, Germany: The first drug to target a key enzyme that cancer cells need to keep them alive has shown that it is effective in controlling disease in patients with advanced kidney cancer when it is used in combination with … Continue reading

Published Wednesday, November 30th, 2016 at 12:01 am
Posted in Cancer
.